PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer

Abstract Background Aberrant epigenetic remodeling events contribute to progression and metastasis of breast cancer (Bca). The specific mechanims that epigenetic factors rely on to mediate tumor aggressiveness remain unclear. We aimed to elucidate the roles of epigenetic protein PHF6 in breast tumor...

Full description

Bibliographic Details
Main Authors: Sheng Gao, Wensheng Zhang, Jingjing Ma, Xiaojian Ni
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04031-8
_version_ 1797859851549802496
author Sheng Gao
Wensheng Zhang
Jingjing Ma
Xiaojian Ni
author_facet Sheng Gao
Wensheng Zhang
Jingjing Ma
Xiaojian Ni
author_sort Sheng Gao
collection DOAJ
description Abstract Background Aberrant epigenetic remodeling events contribute to progression and metastasis of breast cancer (Bca). The specific mechanims that epigenetic factors rely on to mediate tumor aggressiveness remain unclear. We aimed to elucidate the roles of epigenetic protein PHF6 in breast tumorigenesis. Methods Published datasets and tissue samples with PHF6 staining were used to investigate the clinical relevance of PHF6 in Bca. CCK-8, clony formation assays were used to assess cell growth capacity. Cell migration and invasion abilities were measured by Transwell assay. The gene mRNA and protein levels were measured by quantitative real-time PCR and western blot. Chromatin immunoprecipitation (ChIP)-qPCR assays were used to investigate transcriptional relationships among genes. The Co-immunoprecipitation (Co-IP) assay was used to validate interactions between proteins. The CRISPR/Cas9 editing technology was used to construct double HIF knockout (HIF-DKO) cells. The subcutaneous xenograft model and orthotopic implantation tumor model were used to asess in vivo tumor growth. Results In this study, we utilized MTT assay to screen that PHF6 is required for Bca growth. PHF6 promotes Bca proliferation and migration. By analyzing The Cancer Genome Atlas breast cancer (TCGA-Bca) cohort, we found that PHF6 was significantly higher in tumor versus normal tissues. Mechanistically, PHF6 physically interacts with HIF-1α and HIF-2α to potentiate HIF-driven transcriptional events to initiate breast tumorigenesis. HIF-DKO abolished PHF6-mediated breast tumor growth, and PHF6 deficiency in turn impaired HIF transcriptional effects. Besides, hypoxia could also rely on YAP activation, but not HIF, to sustain PHF6 expressions in Bca cells. In addition, PHF6 recuits BPTF to mediate epigenetic remodeling to augment HIF transcriptional activity. Targeting PHF6 or BPTF inhibitor (AU1) is effective in mice models. Lastly, PHF6 correlated with HIF target gene expression in human breast tumors, which is an independent prognostic regulator. Conclusions Collectively, this study identified PHF6 as a prognostic epigenetic regulator for Bca, functioning as a HIF coactivator. The fundamental mechanisms underlying YAP/PHF6/HIF axis in breast tumors endowed novel epigenegtic targets for Bca treatment.
first_indexed 2024-04-09T21:37:19Z
format Article
id doaj.art-d9ec0570e5dd4d83b4eeabcc339e4d4b
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-09T21:37:19Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-d9ec0570e5dd4d83b4eeabcc339e4d4b2023-03-26T11:16:47ZengBMCJournal of Translational Medicine1479-58762023-03-0121111810.1186/s12967-023-04031-8PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancerSheng Gao0Wensheng Zhang1Jingjing Ma2Xiaojian Ni3Department of Breast, Women’s Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care HospitalState Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, Key Laboratory of Reproduction Regulation of NPFPC and Collaborative Innovation Center for Genetics and Development, Fudan UniversityDepartment of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityAbstract Background Aberrant epigenetic remodeling events contribute to progression and metastasis of breast cancer (Bca). The specific mechanims that epigenetic factors rely on to mediate tumor aggressiveness remain unclear. We aimed to elucidate the roles of epigenetic protein PHF6 in breast tumorigenesis. Methods Published datasets and tissue samples with PHF6 staining were used to investigate the clinical relevance of PHF6 in Bca. CCK-8, clony formation assays were used to assess cell growth capacity. Cell migration and invasion abilities were measured by Transwell assay. The gene mRNA and protein levels were measured by quantitative real-time PCR and western blot. Chromatin immunoprecipitation (ChIP)-qPCR assays were used to investigate transcriptional relationships among genes. The Co-immunoprecipitation (Co-IP) assay was used to validate interactions between proteins. The CRISPR/Cas9 editing technology was used to construct double HIF knockout (HIF-DKO) cells. The subcutaneous xenograft model and orthotopic implantation tumor model were used to asess in vivo tumor growth. Results In this study, we utilized MTT assay to screen that PHF6 is required for Bca growth. PHF6 promotes Bca proliferation and migration. By analyzing The Cancer Genome Atlas breast cancer (TCGA-Bca) cohort, we found that PHF6 was significantly higher in tumor versus normal tissues. Mechanistically, PHF6 physically interacts with HIF-1α and HIF-2α to potentiate HIF-driven transcriptional events to initiate breast tumorigenesis. HIF-DKO abolished PHF6-mediated breast tumor growth, and PHF6 deficiency in turn impaired HIF transcriptional effects. Besides, hypoxia could also rely on YAP activation, but not HIF, to sustain PHF6 expressions in Bca cells. In addition, PHF6 recuits BPTF to mediate epigenetic remodeling to augment HIF transcriptional activity. Targeting PHF6 or BPTF inhibitor (AU1) is effective in mice models. Lastly, PHF6 correlated with HIF target gene expression in human breast tumors, which is an independent prognostic regulator. Conclusions Collectively, this study identified PHF6 as a prognostic epigenetic regulator for Bca, functioning as a HIF coactivator. The fundamental mechanisms underlying YAP/PHF6/HIF axis in breast tumors endowed novel epigenegtic targets for Bca treatment.https://doi.org/10.1186/s12967-023-04031-8PHF6BPTFHIFEpigenetic remodelingBreast cancer
spellingShingle Sheng Gao
Wensheng Zhang
Jingjing Ma
Xiaojian Ni
PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
Journal of Translational Medicine
PHF6
BPTF
HIF
Epigenetic remodeling
Breast cancer
title PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
title_full PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
title_fullStr PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
title_full_unstemmed PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
title_short PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer
title_sort phf6 recruits bptf to promote hif dependent pathway and progression in yap high breast cancer
topic PHF6
BPTF
HIF
Epigenetic remodeling
Breast cancer
url https://doi.org/10.1186/s12967-023-04031-8
work_keys_str_mv AT shenggao phf6recruitsbptftopromotehifdependentpathwayandprogressioninyaphighbreastcancer
AT wenshengzhang phf6recruitsbptftopromotehifdependentpathwayandprogressioninyaphighbreastcancer
AT jingjingma phf6recruitsbptftopromotehifdependentpathwayandprogressioninyaphighbreastcancer
AT xiaojianni phf6recruitsbptftopromotehifdependentpathwayandprogressioninyaphighbreastcancer